The role of antitumor antibiotics in current oncologic practice
- 1 June 1978
- journal article
- review article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 1 (2) , 83-90
- https://doi.org/10.1007/bf00254041
Abstract
The antitumor antibiotics have thus made a major impact on oncologic practice. The continued search for productive strains of these organisms should be encouraged; in addition, the activity and toxicity spectrum suggests the need for vigorous analogue development. An active anthracycline devoid of cardiotoxicity, a bleomycin with no effect on pulmonary tissue, an analogue of streptozoticin devoid of nephrotoxicity —these would be advances of inestimable benefit to the cancer patient of the future.Keywords
This publication has 78 references indexed in Scilit:
- HIGH REMISSION-INDUCTION RATE IN ACUTE MYELOID LEUKÆMIAThe Lancet, 1977
- Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomaCancer, 1976
- SMALL-CELL CARCINOMA OF THE LUNG: ATTEMPT TO REMEDY CAUSES OF PAST THERAPEUTIC FAILUREThe Lancet, 1976
- Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group studyCancer, 1976
- Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancerCancer, 1975
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975
- Chemotherapy of gestational choriocarcinomaCancer, 1972
- A decade of combination chemotherapy of advanced Hodgkin's diseaseCancer, 1972
- Clinical trials with bleomycin in lymphomas and in solid tumorsPublished by Elsevier ,1972
- The mode of action of actinomycin DBiochimica et Biophysica Acta, 1960